{"name":"Dale Shepard, MD, PhD","slug":"dale-shepard-md-phd","ticker":"","exchange":"","domain":"","description":"Dale Shepard, MD, PhD, is a clinical and research-focused entity with expertise in oncology, particularly known for its work on Hsp90 inhibitors. The company has a limited public profile and no current commercial products, with its lead drug candidate, AUY922, having been discontinued.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNQ0pnNHJCcG4zOUN4Z0hDUEZCcW5ud0s2RUoyRHBuSndzcms5cmJKcXZ5aTE3ZWVpcE9wSklJNFJuR1EzeUc4WERDeGNwR3JLbDNNZk9VWU5WUlZYNVBBTW1yRWExWG44ZnNVclVHYk1CSmpZTFV6ZjZKek95REFtNVJ0OEkwTDU4YWJyX0VhQXBlTWJnV1IwaGxGQ3VQWmNraXJxdjg2b1RxM3cyQVR2M0tESXRmRU1hM1JJRXdraDVmQTlCMVEtcmN3d1owRWN4SXc?oc=5","date":"2026-03-25","type":"pipeline","source":"Healio","summary":"p53 reactivator exhibits ‘impressive’ activity in heavily pretreated solid tumors - Healio","headline":"p53 reactivator exhibits ‘impressive’ activity in heavily pretreated solid tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFBaMkkwU19Tb1k2OGNTUTJCSVU3SFNidTdEMmlSdlphUDhueGJHbmhWTG94Q3dVeXVmcDB6QjBOSUdlOE01LV9GUHM4OEZGYmxCT0xYWVlWS2dyRTZqVVRWbW9MTTRHbnc1S3k4RQ?oc=5","date":"2025-05-31","type":"regulatory","source":"Docwire News","summary":"FDA Draft Guidance: Reduce Use of Placebo in Clinical Trials - Docwire News","headline":"FDA Draft Guidance: Reduce Use of Placebo in Clinical Trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPbnRyd0FYN3RIMUY3UVBYdFVzdTkwbVN5ckt0Y2RYNGVGUjAxVFZCaWRXNkhhVnNnT3JsYmt2X1hHWjhpdlZRY2g2SlRHZ3lkUmNleW4xRjlVeTVYU0xIcE5QOFROU1JGSWxSTWptcTdhdG84T2ZlRlZSamNZbTlDY0g1NFpLbTViaXZFejFWU3pPWUtvbnlCc0c4ZFZ2NlhteFV6Ng?oc=5","date":"2024-04-11","type":"pipeline","source":"Targeted Oncology","summary":"Nadofaragene Firadenovec Delivers Durable Responses in Bladder Cancer - Targeted Oncology","headline":"Nadofaragene Firadenovec Delivers Durable Responses in Bladder Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPcEpwZTY2cEh3OWxLS0FlVktWMUlDbkNuTG1HS3QxOVFOWWZEd3lCd1plNVpBVldoekFleVJKWWlVUHRwdUNWZGVFQTlyb2FTeWJJRW5xM1o5OFJyZTRIbm1IczZBV3Z3dm1xWHQ4RGlvXzlPNENjUjNMZW9wTFlhQVhTRGp1ZXlrVTdvN19CUzFiMVhxYnA2cTJQM3BaU1ZKdXN5QWRiRkhlRTlOaHdoUkxMQ19ocGJTZ3Y0anp1NVFKNU8za3FUZDBlMUlOSDF6QUJRODRzalNnUQ?oc=5","date":"2023-08-08","type":"pipeline","source":"Healio","summary":"High daily intake of sugar-sweetened beverages linked to 85% greater risk for liver cancer - Healio","headline":"High daily intake of sugar-sweetened beverages linked to 85% greater risk for liver cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1PSDZiVEpQb1NJbWl6MlQzMmJzMFpsVS05UElEVW1QQ3dhS0FKYTNBZFRLd0hIaGtzY1ZKSkRleXJrWGxHcGZaRTZqWVZuS2tKQVVhYjhpT1gzdzZTeWNxY3Y4Rk5qbndwUkNrdWhpSkV0WWpQREh6WlkzZnVjQQ?oc=5","date":"2022-09-27","type":"pipeline","source":"OncLive","summary":"Desmoid Tumors: The Tumor That Isn’t a Cancer - OncLive","headline":"Desmoid Tumors: The Tumor That Isn’t a Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOTkVKa2tMaXdNWnczWUJVU05pQ0k2S3RKX0w0b013QUwtVmFWa1VCZTdvdmVudkJPMDJack8tX05SaGRmcVQteFdzTnhRZ0FRTXYzMS1WS2ROTi0zeEVCNUY5cHhVdGlxeC1sVk0zdE11YUFfSDJVX0NqX3VUbVY3ZXZFVm1XQ09BRmZ5eDZ1YkgwX19TVndsQ3h3c1RaTGRsdXNyN2M0TXZTOGpPQS1DTHVqOFY2VHktMll1b3pR?oc=5","date":"2022-01-27","type":"regulatory","source":"Targeted Oncology","summary":"FDA Grants Breakthrough Therapy Designation to DZD9008 for EGFR Exon20Ins-Positive NSCLC - Targeted Oncology","headline":"FDA Grants Breakthrough Therapy Designation to DZD9008 for EGFR Exon20Ins-Positive NSCLC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPYU1ObDBTQnBjMFlMS3ZsVnExT3BBVVQyNmxzNFVuXzB0MElUUzE1dTBfdlZUYV84N0dSaHFwQmFEYzVOSUpoUFNwZkptejV4dXF4SVFPbjFhSVozbVlPNzRoT1BGLU4wZ0gwWm13TVdIanZ3a0RidjJaRFJkWE5RNXVuWm5jWGg4NUNsVVVTUVB3WUdFLVpIMHBR?oc=5","date":"2021-10-04","type":"pipeline","source":"Cleveland Clinic","summary":"Sarcoma: Continuing the Search for Treatment Alternatives - Cleveland Clinic","headline":"Sarcoma: Continuing the Search for Treatment Alternatives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQWjI2bDhsZ19QWnY1WWt6OGxFbE5zOF9JVEVxLTJQWFN6UWRpeXlhT2hPNGd4YzExY3B0bXVxNGV4UmE3Z2dIQWF0VzVPZV8xazIwRXNKNXlWYklEZ3RyN21qSFdmNkMzdktNZHlLY1drN2dqbUVSMTdxeFF0czFpWGtWaEo2QTJJRHpxTk9n?oc=5","date":"2013-09-01","type":"pipeline","source":"Healio","summary":"Despite headlines, role of statins in cancer prevention far from proven - Healio","headline":"Despite headlines, role of statins in cancer prevention far from proven","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQTHhCc1BzelVGWFI0UnFTYUN5SkJUZkVyblk4S0V6NnIwLWlQT2s5R0c3ZmttZTBXMVRxZUptR29GZHFTM0RVcWRPNTE5YTM4Um5QZ25rOW5hajdyWmVwZlBSWWxVV0hzWVNZaW1iS21EVkpPZkVfanh2TGI2TWc2YkdleUQtZ203X2tFQTBwN1RsVjFvbEpLcGFaVXEyWXVsTEJMTGNDVF9TdzFnWXE3NWVLZ2tzdEItdzlmOW11Wk8wbTFnWmNLeWh3bmVGeGRraUhz?oc=5","date":"2013-05-29","type":"trial","source":"Healio","summary":"Lack of elderly patients in cancer trials leads to inadequate treatment guidance - Healio","headline":"Lack of elderly patients in cancer trials leads to inadequate treatment guidance","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}